Epizyme, Inc
EPZM
EPZM was delisted on the 11th of August, 2022.
60 hedge funds and large institutions have $326M invested in Epizyme, Inc in 2013 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 16 reducing their positions, and 19 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 16
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
10% less funds holding
Funds holding: 67 → 60 (-7)
37% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 19
42% less capital invested
Capital invested by funds: $566M → $326M (-$240M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$24.5M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$15M |
| 3 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$11.8M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$9.25M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$5.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$14M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$12.5M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$11.2M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$5.44M |
| 5 |
SCM
Sigma Capital Management
Stamford,
Connecticut
|
-$5.22M |
EPZM Hedge Fund Activity: Q4 2013 in Review
60 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q4 2013, worth a combined $326M — down 42% from $566M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of EPZM and 12 opened new positions — a net loss of 7 holders — while 16 trimmed existing stakes and 24 added.
The largest buyer was Fidelity Investments, adding an estimated $24.5M. The largest seller was Franklin Resources, exiting entirely with an estimated $14M sold.
- 60 institutional investors held Epizyme, Inc (EPZM) as of Q4 2013, down from 67 in Q3 2013.
- Funds reported $326M of Epizyme, Inc stock for Q4 2013, down 42% quarter-over-quarter.
- 12 funds opened new Epizyme, Inc positions in Q4 2013 and 19 closed out, a net change of -7 holders.
- The largest Epizyme, Inc buyer in Q4 2013 was Fidelity Investments, an estimated $24.5M added.
- The largest Epizyme, Inc seller in Q4 2013 was Franklin Resources, an estimated $14M sold.
Based on aggregated 13F filings for Q4 2013.